本页面由Tiger Trade Technology Pte. Ltd.提供服务

Veru Inc.

2.50
+0.01000.40%
盘后2.500.00000.00%19:56 EST
成交量:5.00万
成交额:12.35万
市值:4,012.60万
市盈率:-2.10
高:2.55
开:2.49
低:2.40
收:2.49
52周最高:7.40
52周最低:2.10
股本:1,605.04万
流通股本:1,448.04万
量比:0.72
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-1.1898
每股收益(LYR):-1.5517
净资产收益率:-60.25%
总资产收益率:-42.92%
市净率:1.08
市盈率(LYR):-1.61

数据加载中...

公司资料

公司名字:
Veru Inc.
交易所:
NASDAQ
成立时间:
1971
员工人数:
20
公司地址:
2916 North Miami Avenue,Suite 1000,Miami,Florida,United States
邮编:
33127
电话:
传真:
- -
简介:
Veru Inc.于1971年在威斯康星州成立。公司是一家临床后期生物制药公司,专注于研发治疗心脏代谢和炎症性疾病的新药。该公司的药物开发计划包括两个晚期新化学实体,enobosarm和sabizabulin。

董事

名称
职位
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Grace Hyun
Director
Loren Katzovitz
Director
Lucy Lu
Director
Michael L. Rankowitz
Director

股东

名称
职位
Mitchell S. Steiner
Chairman of the Board and Chief Executive Officer and Director and President
Michele Greco
Chief Administrative Officer and Chief Financial Officer
Harry Fisch
Chief Corporate Officer and Director and Vice Chairman
K. Gary Barnette
Chief Scientific Officer